| Visualitzacions | |
|---|---|
| A phase I randomized therapeutic MVA-B vaccination improves the magnitude and quality of the T cell immune responses in HIV-1-infected subjects on HAART | 853 |
| octubre 2023 | novembre 2023 | desembre 2023 | gener 2024 | febrer 2024 | març 2024 | abril 2024 | |
|---|---|---|---|---|---|---|---|
| A phase I randomized therapeutic MVA-B vaccination improves the magnitude and quality of the T cell immune responses in HIV-1-infected subjects on HAART | 0 | 3 | 22 | 9 | 1 | 1 | 8 |
| Visualitzacions | |
|---|---|
| artconlli_a2015_brander_christian_phase_randomized.pdf.pdf | 497 |
| artconlli_a2015_brander_christian_phase_randomized.pdf.pdf.txt | 1 |
| Visualitzacions | |
|---|---|
| Estats Units | 488 |
| Suècia | 89 |
| Xina | 50 |
| Alemanya | 44 |
| Ucraïna | 38 |
| Regne Unit | 26 |
| França | 21 |
| Irlanda | 14 |
| Canadà | 13 |
| Espanya | 13 |
| Visualitzacions | |
|---|---|
| Ashburn | 120 |
| Fairfield | 70 |
| Ann Arbor | 55 |
| Sunnyvale | 31 |
| Oakland | 30 |
| Houston | 25 |
| Zhengzhou | 17 |
| Cambridge | 14 |
| Woodbridge | 14 |
| Dublin | 13 |